Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement

FXHvsFHLCETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0.03%
VS
ETF 2
FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of
US Health Care
+0.03%

First Trust Health Care AlphaDEX Fund ETF (FXH) and Fidelity MSCI Health Care Index ETF (FHLC) belong to the same industry segment: US Health Care. FXH's top 1 sector exposures are Healthcare. In contrast, FHLC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. FXH is more expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.084% for FHLC. FXH is up 22.04% year-to-date (YTD) with +$33M in YTD flows. FHLC performs worse with 20.39% YTD performance, and +$495M in YTD flows. Run a side-by-side ETF comparison of FXH and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs FHLC performance and flow charts

Performance

-2.00.02.04.06.08.0%Sep 29Oct 6Oct 13Oct 20Oct 27

Cumulative Flows

-40 M-20 M0 M20 M40 M60 M80 M100 MSep 29Oct 6Oct 13Oct 20Oct 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/29/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
FHLC
+5.30%+8.44%
+8.12%+11.89%
+22.04%+20.39%
+24.54%+29.07%
+56.15%+59.89%
+16.65%+42.33%
Flows
FXH
FHLC
-$39M+$94M
+$26M+$239M
+$33M+$495M
+$39M+$559M
-$459M-$152M
-$464M+$72M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
FHLC
+14.83%+16.64%
+15.69%+15.97%
+15.66%+14.92%
+16.95%+15.52%
Max drawdown
FXH
FHLC
-4.82%-5.64%
-12.07%-10.35%
-17.66%-16.88%
-27.47%-17.78%
Max drawdown duration
FXH
FHLC
55d56d
168d169d
395d435d
1638d762d
Trading data

Create an account to view trading data

Join for free
FXH
FHLC
Last sale
11/2/2026 at 2:30 PM
$137.67
$88.24
Previous close
10/30/2026
$137.44
$88.56
Consolidated volume
10/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FXH
FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/2/2026 at 2:30 PM
Live
Closed
FXH
FHLC
Last price
$137.67
$88.24
1D performance
+0.17%
-0.36%
AuM$1.17 B$3.95 B
E/R0.61%0.084%
Characteristics
FXH
FHLC
Management strategyPassivePassive
ProviderFirst TrustFidelity
BenchmarkStrataQuant Health Care IndexMSCI USA IMI Health Care 25/50 Index
N° of holdings72335
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007October 21, 2013
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
93.54%
Other
6.46%
FHLC
USA
97.27%
Other
2.73%

Sectors

FXH
Healthcare
98.5%
Other
1.5%
FHLC
Healthcare
98.3%
Other
1.7%

Diversification

FXH

Total weight of top 15 holdings out of 15

35.85%
FHLC

Total weight of top 15 holdings out of 15

61.34%

Top 15 holdings

Data as of September 30, 2026
FXH
Natera, Inc.
3.34%
Regeneron Pharmaceuticals, Inc.
2.62%
Universal Health Services, Inc.
2.62%
Pfizer Inc.
2.60%
Guardant Health, Inc.
2.59%
Solventum Corp.
2.53%
Halozyme Therapeutics, Inc.
2.27%
Zimmer Biomet Holdings, Inc.
2.27%
Boston Scientific Corp.
2.25%
Tenet Healthcare Corp.
2.25%
Corcept Therapeutics, Inc.
2.18%
The Cigna Group
2.16%
Centene Corp.
2.11%
Globus Medical, Inc.
2.09%
Medline, Inc.
1.97%
FHLC
Eli Lilly & Co.
13.09%
Johnson & Johnson
9.02%
AbbVie, Inc.
6.45%
Merck & Co., Inc.
5.08%
UnitedHealth Group, Inc.
4.72%
Thermo Fisher Scientific, Inc.
3.47%
Amgen, Inc.
3.09%
Gilead Sciences, Inc.
2.59%
Abbott Laboratories
2.44%
Pfizer Inc.
2.26%
Intuitive Surgical, Inc.
1.98%
Danaher Corp.
1.98%
Vertex Pharmaceuticals, Inc.
1.85%
Bristol Myers Squibb Co.
1.77%
CVS Health Corp.
1.57%
Frequently asked questions about FXH and FHLC

How have the FXH and FHLC ETFs performed in 2026?

As of October 29, 2026, FXH is up 22.04% year-to-date (YTD), while FHLC has returned 20.39%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or FHLC?

Year-to-date, the FXH ETF saw +$33M in flows, compared to +$495M for FHLC.

Which ETF is more volatile: FXH or FHLC?

Over the past year, FXH had a volatility of 15.69%, while FHLC experienced 15.97%.

Which ETF is bigger: FXH or FHLC?

As of October 29, 2026, FXH holds $1.17 B in assets under management (AUM), while FHLC manages $3.95 B.

What sectors do the FXH and FHLC ETFs invest in?

FXH leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the FXH ETF and FHLC ETF?

FXH top holdings include Natera, Inc., Regeneron Pharmaceuticals, Inc. and Universal Health Services, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: FXH or FHLC?

FXH holds 72 securities with 35.85% of its assets in the top 15. FHLC has 335 securities and a top 15 weight of 61.34%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026